Title | Author(s) | Issue date | ???itemlist.??? |
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study | Athyros, V. G.; Karagiannis, A.; Ganotakis, E. S.; Paletas, K.; Nicolaou, V.; Bacharoudis, G.; Tziomalos, K.; Alexandrides, T.; Liberopoulos, E. N.; Mikhailidis, D. P. | 24-Nov-2015 | - |
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort | Athyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S. | 24-Nov-2015 | - |
Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study | Athyros, V. G.; Ganotakis, E. S.; Bathianaki, M.; Monedas, I.; Goudevenos, I. A.; Papageorgiou, A. A.; Papathanasiou, A.; Kakafika, A. I.; Mikhailidis, D. P.; Elisaf, M. S. | 24-Nov-2015 | - |
The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study | Diamantopoulos, E. J.; Athyros, V. G.; Yfanti, G. K.; Migdalis, E. N.; Elisaf, M. S.; Vardas, P. E.; Manolis, A. S.; Karamitsos, D. T.; Ganotakis, E. S.; Hatseras, D. | 24-Nov-2015 | - |
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate | Christidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S. | 24-Nov-2015 | - |
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study | Athyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S. | 24-Nov-2015 | - |
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels | Athyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S. | 24-Nov-2015 | - |
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study | Athyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S. | 24-Nov-2015 | - |
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions | Athyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Mikhailidis, D. P. | 24-Nov-2015 | - |
Prevalence of vascular disease in metabolic syndrome using three proposed definitions | Athyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Liberopoulos, E. N.; Goudevenos, I. A.; Karagiannis, A. | 24-Nov-2015 | - |
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study | Athyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P. | 24-Nov-2015 | - |
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) | Milionis, H. J.; Rizos, E.; Kostapanos, M.; Filippatos, T. D.; Gazi, I. F.; Ganotakis, E. S.; Goudevenos, J.; Mikhailidis, D. P.; Elisaf, M. S. | 24-Nov-2015 | - |